Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

od Aebi, S., Sun, Z., Braun, D., Price, K. N., Castiglione-Gertsch, M., Rabaglio, M., Gelber, R. D., Crivellari, D., Lindtner, J., Snyder, R., Karlsson, P., Simoncini, E., Gusterson, B. A., Viale, G., Regan, M. M., Coates, A. S., Goldhirsch, A.
Wydane 2011

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with nod...

od Karlsson, P., Sun, Z., Braun, D., Price, K. N., Castiglione-Gertsch, M., Rabaglio, M., Gelber, R. D., Crivellari, D., Collins, J., Murray, E., Zaman, K., Colleoni, M., Gusterson, B. A., Viale, G., Regan, M. M., Coates, A. S., Goldhirsch, A.
Wydane 2011

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

od Rabaglio, M., Sun, Z., Price, K. N., Castiglione-Gertsch, M., Hawle, H., Thürlimann, B., Mouridsen, H., Campone, M., Forbes, J. F., Paridaens, R. J., Colleoni, M., Pienkowski, T., Nogaret, J.-M., Láng, I., Smith, I., Gelber, R. D., Goldhirsch, A., Coates, A. S.
Wydane 2009

Symptoms of endocrine treatment and outcome in the BIG 1–98 study

od Huober, J., Cole, B.F., Rabaglio, M., Giobbie-Hurder, A., Wu, J., Ejlertsen, B., Bonnefoi, H., Forbes, J.F., Neven, P., Láng, I., Smith, I., Wardley, A., Price, K.N., Goldhirsch, A., Coates, A.S., Colleoni, M., Gelber, R.D., Thürlimann, B.
Wydane 2013